Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan;103(1):103-108.
doi: 10.1111/cge.14226. Epub 2022 Sep 15.

Expanding the spectrum of KCNJ6-related disorders: Milder phenotype with pathological startle responses

Affiliations
Case Reports

Expanding the spectrum of KCNJ6-related disorders: Milder phenotype with pathological startle responses

Vesna Marija van Midden et al. Clin Genet. 2023 Jan.

Abstract

Keppen-Lubinsky syndrome is caused by pathogenic variants in KCNJ6, which encodes the inwardly rectifying channel subfamily J6. The four confirmed cases reported to date were characterized by severe intellectual disability, global developmental delay, feeding difficulties, and dysmorphic features. All but one of the cases also had a severe form of lipodystrophy, resulting in tightly adherent facial skin and appearance of premature aging. Here, we describe a 36-year-old female with a de novo pathogenic variant in KCNJ6 (NM_002240.5: c.460G>T; p.(Gly154Cys)) presenting with mild intellectual disability, subtle dysmorphic features, obsessive-compulsive disorder, and an exaggerated startle response. This case indicates that KCNJ6-related disorders should be considered in patients with less pronounced dysmorphic features and milder cognitive impairment, as well as in patients with startle disorders.

Keywords: Girk2; KCNJ6; KCNJ6-related disorders; Keppen-Lubinsky syndrome; case report; startle response.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no conflict of interest exists.

Figures

FIGURE 1
FIGURE 1
Facial lipodystrophy at 1 and 36 years [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 2
FIGURE 2
Gene structure, position of Gly154 in the selectivity filter of KCNJ6, and its conservation across species. (A) Gene structure with all reported cases of a KCNJ6‐related disorder in English literature marked in red. (B) KCNJ6 structure (Mus musculus crystal structure; Protein Data Bank number SYO3) visualized with ChimeraX. The channel is composed of four chains (in different colors), potassium ions are shown in purple, Gly154 is shown in red. (C) Close‐up of the KCNJ6 selectivity filter, Gly154 is shown in red. (D) Conservation of the selectivity filter Thr151–Val 159 across different species, Gly154 is marked with a red rectangle; * indicates that the amino acid is conserved across all selected species [Colour figure can be viewed at wileyonlinelibrary.com]

Similar articles

References

    1. Cunningham ML. Syndromes of the head and neck, fourth edition, by R.J. Gorlin, M.M. Cohen, and R.C.M. Hennekam. Am J Med Genet. 2002;113(3):312. doi:10.1002/AJMG.10768 - DOI
    1. Brasi DD, Brunetti‐Pierri N, Micco PD, Andria G, Sebastio G. New syndrome with generalized lipodystrophy and a distinctive facial appearance: confirmation of Keppen‐Lubinski syndrome? Am J Med Genet A. 2003;117A(2):194‐195. doi:10.1002/AJMG.A.10936 - DOI - PubMed
    1. Masotti A, Uva P, Davis‐Keppen L, et al. Keppen‐Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6. Am J Hum Genet. 2015;96(2):295‐300. doi:10.1016/J.AJHG.2014.12.011 - DOI - PMC - PubMed
    1. Horvath GA, Zhao Y, Tarailo‐Graovac M, et al. Gain‐of‐function KCNJ6 mutation in a severe hyperkinetic movement disorder phenotype. Neuroscience. 2018;384:152‐164. doi:10.1016/J.NEUROSCIENCE.2018.05.031 - DOI - PMC - PubMed
    1. Basel‐Vanagaite L, Shaffer L, Chitayat D. Keppen‐Lubinsky syndrome: expanding the phenotype. Am J Med Genet A. 2009;149A(8):1827‐1829. doi:10.1002/AJMG.A.32975 - DOI - PubMed

Publication types

MeSH terms

Substances